• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.12% Nasdaq Up 0.71%

    Exelixis, Inc. (EXEL)

    -NasdaqGS
    3.08 Down 0.02(0.65%) Apr 24, 4:00PM EDT
    |After Hours : 3.09 Down 0.01 (0.16%) Apr 24, 4:00PM EDT
    Add to Portfolio
    Prev Close:3.10
    Open:3.09
    Bid:2.55 x 800
    Ask:3.12 x 5000
    1y Target Est:2.50
    Beta:1.74
    Next Earnings Date:30-Apr-15EXEL Earnings announcement
    Day's Range:3.07 - 3.14
    52wk Range:1.26 - 4.55
    Volume:1,453,651
    Avg Vol (3m):3,892,570
    Market Cap:603.44M
    P/E (ttm):N/A
    EPS (ttm):-1.38
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    EXELDown 0.65%603.44M
    AZNDown 1.83%90.68B
    GSKUp 0.60%112.07B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):24.18
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.86
    Quarterly EPS Est (Mar-15) :-0.24
    Mean Recommendation*:2.6
    PEG Ratio (5 yr expected):0.15

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Exelixis, Inc., a biopharmaceutical company, develops and sells small molecule therapies for the treatment of cancer in the United States. The company offers COMETRIQ, an inhibitor of multiple receptor tyrosine kinases for the treatment of patient... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback